--- canonical_name: Glycine alternate_names: Aminoacetic Acid, Glycocoll, Gly canonical_topic: Glycine for Health & Longevity short_topic_lc: glycine creation_date: 2026-0719-0123 creator_ai_fullname: Opus 4.8 --- # Glycine for Health & Longevity
Evidence Review created on 07/19/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Opus 4.8 **Also known as:** Aminoacetic Acid, Glycocoll, Gly ## Motivation Glycine is the smallest of the twenty amino acids that build the body's proteins. The body makes its own glycine and also takes it in from foods such as meat, fish, and the collagen-rich parts of animals, so it is not considered strictly essential. Yet interest has grown because the amounts the body makes may fall short of what is needed for tasks such as building collagen, making the antioxidant glutathione, and calming the nervous system, especially as people age. Glycine has a long history as a cheap, widely available food ingredient and a sweet-tasting powder. Much of the recent attention comes from a striking observation: in laboratory animals, adding glycine to the diet lengthened lifespan, and small human studies suggested it may improve sleep and lower markers of stress inside cells. These findings placed glycine on the list of low-cost compounds now studied for healthy aging. This review examines what is known about glycine when taken as a supplement by adults focused on long-term health. It looks at how glycine works in the body, the benefits and risks reported in human and animal research, how it is typically used, and where the evidence is still thin or uncertain. **[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)** ## Recommended Reading This section lists high-level, expert-authored resources that discuss glycine directly and give useful context for a health- and longevity-oriented reader. * [Supplemental glycine and cysteine restore glutathione levels and correct several markers of aging](https://www.foundmyfitness.com/stories/hxhna0/supplemental_glycine_and_cysteine_restore_glutathione_levels_and_correct_several_markers_of_aging) - Rhonda Patrick A FoundMyFitness Science Digest entry summarizing the 36-week trial in which glycine plus cysteine restored cellular glutathione and improved several aging markers in older adults. It is a concise entry point to the glycine–glutathione–aging connection that drives much current interest. * [#394 – Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements](https://peterattiamd.com/sleeppharmacology/) - Peter Attia A podcast episode that places glycine among the common supplements used for sleep and weighs the strength of the evidence behind it against behavioral foundations. Useful for understanding where a calming amino acid realistically fits in a sleep strategy. * [Sleep Toolkit: Tools for Optimizing Sleep & Sleep-Wake Timing](https://www.hubermanlab.com/episode/sleep-toolkit-tools-for-optimizing-sleep-and-sleep-wake-timing) - Andrew Huberman A comprehensive sleep episode with a dedicated segment on glycine as an occasional sleep aid, including practical dosing and the caution that it is best reserved for difficult nights rather than nightly use. * [The Bountiful Benefits of Bone Broth: A Comprehensive Guide](https://chriskresser.com/the-bountiful-benefits-of-bone-broth-a-comprehensive-guide/) - Chris Kresser A detailed guide to bone broth that explains why glycine is one of its key active amino acids and how the modern diet may under-supply it relative to traditional nose-to-tail eating. Helpful dietary context for glycine intake beyond supplements. * [Glycine: The Sleepy Amino Acid](https://www.lifeextension.com/wellness/supplements/glycine-for-sleep) - Holly Denton A consumer-facing article focused on glycine's role in sleep and its broader whole-body effects, written in accessible language with references to the underlying human trials. ## Grokipedia * [Glycine](https://grokipedia.com/page/Glycine) The Grokipedia article provides a structured, referenced overview of glycine's chemistry, metabolism, physiological roles, and health implications, useful as a neutral background reference to orient a reader before the evidence sections. ## Examine * [Glycine](https://examine.com/supplements/glycine/) Examine's dedicated glycine page grades the human evidence outcome by outcome (sleep, metabolic health, schizophrenia symptoms, and more) and is a rigorous, continually updated summary of what the trials actually show. ## ConsumerLab * [Glycine Supplement Review & Top Pick](https://www.consumerlab.com/reviews/glycine-review-comparisons/glycine/) ConsumerLab independently tested ten glycine powders and capsules for label accuracy and heavy-metal contamination and named top picks, making it the most relevant resource for choosing a clean, fairly priced product. ## Systematic Reviews The following systematic reviews and meta-analyses represent the highest-quality synthesized human evidence located for glycine supplementation; glycine-specific reviews remain few, so only qualifying papers are listed. * [The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review](https://pubmed.ncbi.nlm.nih.gov/37851316/) - Soh et al., 2024 This review of 52 studies across eleven physiological systems found the strongest signals for the nervous system, including improved sleep in healthy people and improved psychiatric symptoms in patients, while noting that sleep trials were small and at high risk of bias. It is the most comprehensive human overview of glycine as a candidate healthy-aging compound. * [Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials](https://pubmed.ncbi.nlm.nih.gov/33406959/) - Goh et al., 2021 Pooling 40 trials in 4,937 patients, this meta-analysis found that glutamate-receptor modulators added to antipsychotics improved symptoms, with glycine among the most effective agents (except alongside clozapine). It is the best evidence that oral glycine meaningfully reaches and modulates the central nervous system. ## Mechanism of Action Glycine is the simplest amino acid and plays several distinct roles that make it relevant to health and aging. * **Dual neurotransmitter action:** In the brainstem and spinal cord, glycine is the main inhibitory (calming) neurotransmitter, binding glycine receptors that open chloride channels and quiet nerve firing. In the forebrain it plays the opposite role as a required co-activator at NMDA (N-methyl-D-aspartate) receptors — the glutamate receptors central to learning and memory. This dual action explains both its calming, sleep-related effects and its studied use in schizophrenia. * **Sleep and body temperature:** Taken before bed, glycine acts on NMDA receptors in the suprachiasmatic nucleus (the brain's master clock) and promotes widening of surface blood vessels. This causes a small drop in core body temperature, a natural signal for sleep onset, and is the proposed mechanism for faster sleep onset and better subjective sleep quality. * **Building block for key molecules:** Glycine is a required substrate for glutathione (the body's principal internal antioxidant, made from glycine, cysteine, and glutamate), creatine, heme (the oxygen-carrying part of blood), and purines. It also makes up roughly one-third of collagen, the main structural protein of skin, tendon, and bone. * **One-carbon and mitochondrial metabolism:** Glycine is interconverted with serine by the enzyme SHMT (serine hydroxymethyltransferase) and broken down by the mitochondrial glycine cleavage system (GCS), feeding one-carbon units used to build DNA and methyl groups. Shortfalls here are one proposed reason supplemental glycine may help older or metabolically stressed people. * **Anti-inflammatory signaling:** Glycine-gated chloride channels are present on immune cells such as macrophages and liver Kupffer cells; glycine can dampen their release of inflammatory signals, a mechanism seen mainly in laboratory and animal models. Where mechanistic views compete: some researchers argue that the calming, glutathione-restoring, and longevity-promoting effects reflect correction of a genuine dietary glycine shortfall, while others hold that endogenous synthesis is sufficient and that supplement effects are small and non-specific. Both positions remain live. As a naturally occurring amino acid rather than a drug, glycine has no cytochrome-P450 (liver drug-metabolizing enzyme) processing; it is handled by the glycine cleavage system, renal reabsorption, and incorporation into proteins. Its plasma half-life is short (on the order of a few hours), which is why timed dosing (for example, before bed) matters. ## Historical Context & Evolution * **Original use:** Glycine was first isolated from gelatin in 1820 and named for its sweet taste. For most of its history it was regarded simply as a non-essential amino acid and a food ingredient — a sweetener, buffering agent, and component of intravenous and oral rehydration solutions — with no special health claims. * **Why it came to be considered for health optimization:** Interest shifted as researchers recognized glycine as the rate-limiting building block for glutathione and collagen, and as the smallest inhibitory neurotransmitter. Japanese trials in the 2000s reported that a few grams before bed improved sleep, and analyses of the modern diet suggested humans may fall short of the glycine needed for optimal collagen turnover. * **Findings, not just reception:** In animal studies, glycine supplementation extended lifespan and improved metabolic markers, and it reversed several biochemical signs of aging in tissue and rodent models. Small human trials reported restored glutathione, lower oxidative stress, and improved metabolic markers, particularly when glycine was combined with N-acetylcysteine. * **Evolution of opinion:** Early enthusiasm has been tempered by the recognition that most human trials are small, short, and sometimes industry-linked, and that the dramatic lifespan data come from animals. The current view is not settled: glycine sits among several inexpensive, plausible healthy-aging candidates awaiting larger and longer human trials, and new evidence continues to arrive on both the promising and the cautionary side. ## Expected Benefits The benefits below are grouped by the strength of the human evidence. Because this review is written for health- and longevity-oriented adults, the framing emphasizes effects relevant to that group rather than to any specific patient population. ### Medium 🟩 🟩 #### Improved Sleep Quality and Faster Sleep Onset Several small randomized controlled trials (RCTs, studies that randomly assign a real treatment or a dummy) found that about 3 g of glycine taken roughly an hour before bed shortened the time to fall asleep, improved subjective sleep quality, and reduced next-day sleepiness in people with mild sleep complaints. The proposed mechanism is a small glycine-induced drop in core body temperature. The 2024 systematic review judged this the most consistent glycine effect while cautioning that the trials were small and at high risk of bias. **Magnitude:** In small polysomnography trials (roughly 10–20 participants), 3 g before bed shortened measured sleep-onset latency and improved sleep-quality and daytime-performance scores; absolute effect sizes are modest and imprecise. #### Support of Glutathione Synthesis and Reduced Oxidative Stress Glycine is one of three building blocks of glutathione, and older adults often have both lower glycine and lower glutathione. Supplementation — most convincingly as glycine plus N-acetylcysteine (NAC, a cysteine donor), together called GlyNAC — restored red-blood-cell glutathione and lowered markers of oxidative stress in small trials of older adults. Glycine alone supplies the rate-limiting substrate, but most of the clinical healthy-aging evidence involves the combination rather than glycine by itself. **Magnitude:** In small GlyNAC trials, red-cell glutathione roughly doubled toward youthful levels over 12–24 weeks with markers of oxidative stress falling substantially; the independent contribution of glycine alone is not separately quantified. ### Low 🟩 #### Improved Glucose Metabolism and Metabolic-Syndrome Markers Small human trials and observational data link glycine to better glucose handling; people with obesity, type 2 diabetes, and fatty liver consistently show lower blood glycine. Short trials of a few grams daily reported modest improvements in markers such as fasting glucose and hemoglobin A1c (HbA1c, a three-month blood-sugar average), though studies are small and inconsistent. **Magnitude:** Reported reductions in HbA1c and fasting glucose are small (typically a fraction of a percentage point for HbA1c) and not consistently reproduced. #### Anti-Inflammatory Activity Through glycine-gated chloride channels on immune cells, glycine can reduce release of inflammatory signals. Human data are limited to small studies showing lower inflammatory markers, and the effect is clearer in laboratory and animal models than in people. **Magnitude:** Not quantified in available studies. #### Connective-Tissue and Collagen Support Because glycine makes up about a third of collagen, adequate intake is required for collagen turnover in skin, tendon, and bone. A dietary-shortfall analysis argues that typical intake may be roughly 10 g/day below optimal for collagen synthesis, but direct trials of glycine alone on skin, joint, or bone outcomes are largely absent. **Magnitude:** A proposed daily shortfall of roughly 10 g relative to optimal collagen-synthesis needs; clinical outcomes not directly quantified for glycine alone. #### Association with Lower Cardiovascular Risk Large observational studies find that people with higher circulating glycine have a lower risk of coronary heart disease (narrowing of the heart's arteries). Whether raising glycine with supplements lowers risk is unproven, and genetic (Mendelian randomization) analyses have given mixed results. **Magnitude:** Higher circulating glycine is associated with modestly lower coronary heart disease risk in cohort studies; a causal, supplement-driven effect is not established. ### Speculative 🟨 #### Lifespan Extension (Geroprotection) Adding glycine to the diet extended lifespan in mice and other model organisms, and glycine improves several aging-related biochemical measures. No human study has tested whether glycine lengthens lifespan or healthspan, so this benefit rests on animal and mechanistic data only. #### Improvement of Fatty Liver Disease Low glycine is tied to metabolic dysfunction-associated steatotic liver disease (MASLD, fat accumulation in the liver), and animal work suggests glycine reduces liver fat and inflammation. Human evidence is limited to associations and early-stage trials now underway, so any benefit is presently mechanistic and anecdotal. #### Muscle Preservation, Performance, and Recovery Glycine supplies substrate for creatine and may activate muscle-building pathways while blunting muscle breakdown in cell and animal studies. A few small human studies suggest possible effects on power output and recovery, but controlled human evidence is preliminary. ## Benefit-Modifying Factors * **Baseline glycine and glutathione levels:** People who start with low glycine — common in older adults and those with obesity, diabetes, or fatty liver — appear most likely to benefit, since supplementation corrects a genuine shortfall rather than adding to an adequate supply. * **Genetic polymorphisms:** Variants in glycine-handling enzymes (for example the glycine cleavage system genes such as GLDC, and SHMT, which shuttles glycine and serine) can shift how efficiently glycine is used or cleared, potentially altering the response, though this is not yet used to guide dosing. * **Age:** Older adults tend to have lower glycine and glutathione and higher oxidative stress, so those at the older end of the target range may see larger effects on sleep and cellular antioxidant status than younger, healthy people. * **Pre-existing metabolic conditions:** Insulin resistance and fatty liver are associated with depressed glycine levels; individuals with these conditions may respond more on metabolic markers than metabolically healthy individuals. * **Sex-based differences:** Human trials have not been powered to detect sex differences in glycine response; some collagen-related work reports differing magnitudes by sex, but robust sex-specific data are lacking. ## Potential Risks & Side Effects Glycine is generally recognized as safe as a food ingredient and is well tolerated in trials. The items below reflect the limited harms that have been reported, framed for otherwise-healthy adults. ### Medium 🟥 🟥 #### Gastrointestinal Upset at High Doses The most common complaint is mild digestive upset — nausea, soft stools, or stomach discomfort — usually only at large single doses. Independent testing notes that very high daily intakes may provoke nausea and vomiting in some people. Effects are dose-related and reversible on lowering the dose. **Magnitude:** Nausea and vomiting have been reported at intakes above roughly 40 g/day; typical supplemental doses of 3–15 g/day are usually well tolerated. ### Low 🟥 #### Daytime Drowsiness or Sedation Because glycine is calming and can promote sleep onset, some users notice mild drowsiness, particularly if a large dose is taken during the day. This is an extension of the intended sleep effect rather than a toxic reaction. **Magnitude:** Not quantified in available studies. #### Reduced Antipsychotic Effect with Clozapine In schizophrenia trials, adding glycine did not help — and may have slightly worked against — the antipsychotic clozapine, unlike other antipsychotics. This is relevant only to the small subset of users taking clozapine, but it is a documented, reproducible signal. **Magnitude:** Meta-analysis found glycine augmentation ineffective specifically alongside clozapine, in contrast to benefit with other antipsychotics. #### Nitrogen Load in Advanced Kidney Disease Glycine is metabolized to nitrogen-containing waste cleared by the kidneys. In people with significantly reduced kidney function, large amino-acid loads can add to that burden, so caution is warranted at high doses. **Magnitude:** Not quantified in available studies. ### Speculative 🟨 #### Theoretical NMDA-Mediated Excitatory Effects Because glycine co-activates NMDA glutamate receptors, very high or sustained exposure has raised a theoretical concern about over-excitation of nerve cells. No such harm has been demonstrated in healthy people at supplemental doses, so this remains a mechanistic caution only. ## Risk-Modifying Factors * **Kidney function:** Reduced kidney function is the clearest modifier; those with meaningfully impaired kidneys should be cautious with high doses because of added nitrogen clearance demands. * **Concurrent clozapine use:** Individuals taking clozapine are the one group with a documented reason to avoid glycine augmentation, since it may blunt that drug's benefit. * **Genetic polymorphisms:** Rare inherited disorders of glycine metabolism (for example glycine encephalopathy from glycine cleavage system defects) cause glycine accumulation; people with such conditions are an exception to glycine's general safety, though these are diagnosed in childhood and not part of the target audience. * **Sex-based differences:** No reliable sex-based differences in glycine side effects have been established in human trials. * **Age and dose sensitivity:** Older adults or those sensitive to sedatives may notice drowsiness more readily, particularly with daytime dosing; starting low mitigates this. ## Key Interactions & Contraindications * **Prescription drugs:** The main documented interaction is with clozapine (an atypical antipsychotic), where glycine may reduce effectiveness — caution, avoid combining without specialist oversight. Glycine may add to the effect of sedating or central-nervous-system-depressant medications (severity: caution; consequence: increased drowsiness). * **Over-the-counter medications:** Combining glycine with over-the-counter sleep aids such as sedating antihistamines (diphenhydramine, doxylamine) may increase drowsiness (severity: monitor; separate timing or reduce dose). * **Supplement interactions:** Additive calming or pro-sleep effects are expected with other sleep and relaxation supplements — magnesium, melatonin, L-Theanine, GABA (gamma-aminobutyric acid, a calming neurotransmitter), and valerian (severity: monitor; consequence: additive sedation). * **Additive NMDA-modulating supplements:** Other NMDA co-agonists such as D-Serine and sarcosine act on the same receptor site as glycine; combining them could compound central effects (severity: caution; monitor for over-stimulation or agitation). * **Other interventions:** As a glutathione precursor, glycine is commonly and deliberately paired with N-acetylcysteine (as GlyNAC); this is an intended additive combination rather than an adverse one. * **Populations who should avoid or use caution:** People taking clozapine; people with advanced kidney disease (for example chronic kidney disease stage 4–5, roughly eGFR — estimated kidney filtration rate — below 30); anyone with a known inherited disorder of glycine metabolism; and, given limited data, pregnant or breastfeeding individuals should use only under professional guidance. ## Risk Mitigation Strategies * **Start low and build up:** Begin at 1–3 g/day and increase gradually toward a target (for example 5 g) over one to two weeks — this limits the main risk, dose-related gastrointestinal upset, while confirming tolerance. * **Cap single doses:** Keep individual doses within the well-tolerated 3–5 g range and split larger daily totals; this prevents the nausea associated with very large single intakes (above roughly 15 g at once, and especially above 40 g/day). * **Time calming doses for the evening:** Take the largest dose before bed to turn glycine's mild sedation into a benefit and avoid daytime drowsiness. * **Screen medications first:** Confirming that clozapine is not among current medications and reviewing other sedatives before use avoids reduced antipsychotic effect or additive drowsiness. * **Respect kidney status:** If kidney function is reduced, keep doses modest and monitor kidney markers, mitigating the added nitrogen-clearance burden. * **Dissolve powder well and take with fluid:** Mixing glycine powder fully in water or a beverage reduces the chance of stomach discomfort and improves palatability. ## Therapeutic Protocol * **Standard sleep protocol:** The most-studied use is 3 g of glycine dissolved in water taken about 30–60 minutes before bed, as popularized in the Japanese sleep trials and echoed by sleep-focused practitioners. * **General and metabolic protocol:** For broader metabolic and antioxidant goals, practitioners commonly use 3–5 g/day, sometimes titrated toward 10–15 g/day in divided doses, reflecting doses used in metabolic trials. * **GlyNAC (glutathione) protocol:** For glutathione restoration in older adults, glycine is combined with N-acetylcysteine, typically dosed by body weight (glycine near 100 mg per kg of body weight per day, with matching N-acetylcysteine), split across the day — the approach used by the research groups that popularized it. * **Competing approaches:** Some favor obtaining glycine from whole-food sources (bone broth, gelatin, collagen peptides) rather than isolated powder; neither dietary nor supplemental sourcing is framed here as the default, and collagen peptides deliver glycine alongside proline and hydroxyproline. * **Best time of day:** Evening dosing suits sleep and calming goals; metabolic protocols spread doses across meals. * **Half-life and dose splitting:** Glycine's short plasma half-life (a few hours) means split dosing maintains steadier levels for metabolic goals, while a single bedtime dose is appropriate for sleep. * **Genetic considerations:** No validated pharmacogenetic dosing exists; variants in glycine cleavage system and SHMT enzymes may in theory alter handling but are not currently used to set doses. * **Sex-based considerations:** No sex-specific dosing is established; body-weight-based GlyNAC dosing inherently adjusts for size. * **Age considerations:** Older adults, who tend to have lower baseline glycine, are the group in which weight-based and metabolic protocols have most often been studied; starting low remains prudent. * **Baseline biomarkers:** Low fasting glycine or low glutathione status, where measured, may identify those most likely to respond and can guide whether to pursue a metabolic protocol. * **Pre-existing conditions:** Metabolic syndrome, fatty liver, or poor sleep are the presentations most aligned with the studied protocols; kidney impairment argues for conservative dosing. ## Discontinuation & Cycling * **Lifelong vs short-term:** Glycine can be used short-term (for example nightly for sleep during a stressful period) or ongoing; there is no established requirement for lifelong use, and its role is supportive rather than corrective of a defined deficiency in most users. * **Withdrawal effects:** No withdrawal syndrome is recognized. Stopping glycine used for sleep may simply return sleep to its prior baseline. * **Tapering:** Tapering is not required given the absence of dependence or rebound; the dose can be stopped directly. * **Cycling:** No evidence indicates that cycling improves or preserves efficacy; glycine does not appear to lose effect with continued use, so routine cycling is not needed. Users may naturally use it intermittently (for example only on nights sleep is a problem, an approach some sleep experts prefer). ## Sourcing and Quality * **Form:** Supplemental glycine is a single, free-form amino acid; independent testing notes that all products contain the same free glycine, so paying a premium is rarely justified. It comes as an unflavored, mildly sweet powder or in capsules. * **What to look for:** Choose products with third-party testing (for example ConsumerLab, NSF, or USP) confirming label accuracy and screening for heavy metals such as arsenic, cadmium, lead, and mercury; independent testing of glycine powders and capsules found claimed amounts were generally accurate. * **Powder vs capsules:** Powder is far cheaper per gram and easy to dissolve for multi-gram doses; capsules are convenient but require many to reach several grams. * **Reputable brands:** Products from Thorne, NOW, Pure Encapsulations, Life Extension, Nutricost, and BulkSupplements were among those independently evaluated; cost to obtain 3 g ranged from roughly 9 cents to over one dollar depending on brand and form. * **Practical selection:** For multi-gram daily use, a plain bulk powder that has passed third-party testing typically offers the best combination of purity and value. ## Practical Considerations * **Time to effect:** Sleep effects can appear the first night, whereas metabolic and antioxidant changes in trials took weeks to months of consistent use. * **Common pitfalls:** Under-dosing (using a few hundred milligrams rather than grams), expecting strong sedation like a prescription sleep medication (glycine is gently calming, not hypnotic), and giving up before a metabolic protocol has run long enough are the usual mistakes. * **Regulatory status:** In the United States glycine is sold as a dietary supplement and is also a generally-recognized-as-safe food ingredient; it is not a prescription drug and its supplement claims are not pre-approved by regulators. * **Cost and accessibility:** Glycine is inexpensive, widely available without prescription, and among the cheapest supplements per effective dose, so cost and access are rarely limiting. * **Palatability:** Its natural sweetness makes powder easy to take in water, unlike many supplements. ## Interaction with Foundational Habits * **Sleep:** Direct and generally positive — taken before bed, glycine can shorten sleep onset and improve subjective sleep quality via a small drop in core body temperature. Practical note: dose 30–60 minutes before bed; reserve higher doses for nights when sleep is difficult, as some experts advise against nightly reliance. * **Nutrition:** Direct interaction with the diet's amino-acid supply. Glycine is concentrated in collagen-rich foods (bone broth, gelatin, skin, connective tissue) that the modern muscle-meat-focused diet under-supplies; glycine also balances methionine (abundant in muscle meat), a proposed reason its ratio to methionine matters for healthy aging. Foods to include: bone broth, gelatin, collagen peptides. * **Exercise:** Mostly indirect and potentially supportive — glycine supplies substrate for creatine and collagen and may aid recovery and connective-tissue repair; it does not appear to blunt training adaptations. Timing relative to workouts is not critical. * **Stress management:** Indirect and potentially potentiating of relaxation — as an inhibitory neurotransmitter, glycine has a calming influence that may complement stress-reduction practices; evidence is mechanistic and from sleep studies rather than dedicated stress trials. ## Monitoring Protocol & Defining Success Baseline testing before starting helps identify who is most likely to benefit (for example those with metabolic or oxidative-stress markers out of range) and provides a reference point. The panel below is most relevant when glycine is used for metabolic or healthy-aging goals rather than occasional sleep support. Ongoing monitoring for metabolic or long-term use is reasonable at roughly 3 months after starting and then every 6–12 months, or sooner if kidney function is a concern. | Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes | |-----------|--------------------------|-----------------|----------------| | Fasting glucose | 70–85 mg/dL | Tracks glucose metabolism, a plausible glycine target | Fast 8–12 h; morning draw | | Hemoglobin A1c (HbA1c) | < 5.4% | Three-month blood-sugar average | Not fasting-dependent; conventional cutoff for concern is higher (≥ 5.7%) | | hs-CRP | < 1.0 mg/L | General marker of inflammation | High-sensitivity C-reactive protein; avoid testing during acute illness; conventional low-risk cutoff is < 3.0 mg/L | | Triglycerides | < 80 mg/dL | Metabolic-health marker linked to low glycine | Requires 8–12 h fast; conventional normal is < 150 mg/dL | | ALT / AST | ALT < 25 U/L (women), < 30 U/L (men) | Screens liver health relevant to fatty-liver goals | Alanine/aspartate aminotransferase (liver enzymes); pair with metabolic panel; conventional upper limits are higher | | Creatinine and eGFR (kidney filtration) | eGFR > 90 mL/min/1.73m² | Confirms kidney capacity before higher doses | Key safety test if using large amino-acid doses | | Homocysteine | 5–7 µmol/L | Reflects one-carbon metabolism that glycine feeds | Best paired with B-vitamin status; morning fasting draw | | Glutathione (red-blood-cell) | Lab-specific; higher within range preferred | Direct readout of the antioxidant glycine helps build | Specialized test; most relevant for GlyNAC protocols | Qualitative markers of success are often more meaningful day to day: * Sleep quality and how quickly sleep comes * Daytime energy and alertness * Recovery from exercise and general sense of well-being * Cognitive clarity ## Emerging Research * **Dietary glycine in fatty liver disease:** A planned randomized placebo-controlled trial is testing 26 weeks of glycine supplementation on liver-health measures in metabolic dysfunction-associated steatotic liver disease ([NCT07285135](https://clinicaltrials.gov/study/NCT07285135), not yet recruiting, about 60 participants) — one of the few trials of glycine alone rather than in combination. * **GlyNAC and knee-surgery outcomes:** A phase 4 trial is evaluating glycine plus N-acetylcysteine against oxidative stress and chronic post-surgical pain after total knee replacement ([NCT06083480](https://clinicaltrials.gov/study/NCT06083480), recruiting, about 148 participants, testing a primary outcome of reduced oxidative stress and pain). * **GlyNAC in Alzheimer's disease:** An early-phase trial is testing glycine plus N-acetylcysteine versus alanine on brain metabolism, inflammation, and cognition in Alzheimer's disease ([NCT04740580](https://clinicaltrials.gov/study/NCT04740580), recruiting, about 52 participants). * **GlyNAC in mild cognitive impairment:** An exploratory trial is examining glutathione precursors (N-acetylcysteine and glycine) versus alanine on mechanisms tied to cognition ([NCT03493178](https://clinicaltrials.gov/study/NCT03493178), active, not recruiting, about 60 participants). * **Larger, longer human trials of glycine alone:** Reviewers emphasize that the strongest healthy-aging signals still come from small, short, biased studies; adequately powered trials in healthy adults are the key future need ([Soh et al., 2024](https://pubmed.ncbi.nlm.nih.gov/37851316/)) — a direction that could strengthen or weaken the case. * **Cardiovascular causality:** Human-genetics and mouse work continues to probe whether glycine is causally protective for coronary artery disease or merely a marker of health, with mixed findings so far ([Biswas et al., 2025](https://pubmed.ncbi.nlm.nih.gov/39796632/)) — evidence that could cut either way. ## Conclusion Glycine is the smallest amino acid and one the body both makes and obtains from food, yet the amount available may fall short of what is needed for building collagen, making the body's main internal antioxidant, and calming the nervous system, especially with age. It is cheap, sweet-tasting, and very well tolerated, which is part of why it has become a candidate for supporting long-term health. The clearest human signal is for sleep: a few grams before bed appears to help some people fall asleep sooner and rest more soundly, though the studies are small. Glycine also supplies a key building block for the body's antioxidant defenses, and it is often paired with another amino acid to restore those defenses in older adults. Effects on blood sugar, inflammation, connective tissue, and heart health are plausible but rest on limited or indirect evidence, and the striking lifespan gains seen in animals have not been tested in people. Overall, glycine offers a favorable balance of low cost, strong safety, and a plausible but still-unproven role in healthy aging. Much of the human research is small, short, or paired with other compounds, so the case remains promising rather than settled, and the sensible reading is one of cautious, evidence-aware interest. **[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**